CAS: 13729-77-6; 2-Methylpiperidin-4-One Hydrochloride
该化合物是一种化学化合物,其特征为管状环结构,由六人组成,内含一个氮原子;该化合物一般是白色至白晶状固体,可溶于水和各种有机溶剂,可适用于不同用途;由于能够参与各种化学反应,包括核生殖替代和循环,它经常被用作合成药品和农用化学品的一个中间体;在2号位置和4号位置的碳基组的存在有助于它的再活动及潜在的生物活动;与许多化学物质一样,在处理2-甲基-4-氢丙酮氢氯化物时,应当采取安全措施,因为如果浸入或吸入,可能会对健康造成危害;还应保持适当的储存条件,以确保稳定性和防止退化.
相似化合物
790667-45-7 1434126-97-2 190906-92-4MSDS等安全信息
合成工艺路线路线简述
📜1-叔丁氧羰基-2-甲基-哌啶酮置于盐酸体系中,用 乙醚 用作溶剂,化学反应 2.0H,反应生成2-甲基-4-哌啶酮盐酸盐
参考文献: Heterobicyclo-Substituted-[1,2,4]Triazolo[1,5-C]Quinazolin-5-Amine Compounds With A2A Antagonist Properties[fr] Composés [1,2,4]Triazolo[1,5-C]Quinazolin-5-Amines à Substitution Hétérobicyclique Ayant Des Propriétés D'Antagonistes Du Récepteur A2A
标题: Heterobicyclo-Substituted-[1,2,4]Triazolo[1,5-C]Quinazolin-5-Amine Compounds With A2A Antagonist Properties[fr] Composés [1,2,4]Triazolo[1,5-C]Quinazolin-5-Amines à Substitution Hétérobicyclique Ayant Des Propriétés D'Antagonistes Du Récepteur A2A
摘要:揭示了formula Gl(结构表示如下)的化合物:其中"rg3","rd1"至"rd4","n","m","p","w","x","y"和"z"在此处被定义,这些化合物是a2A受体的拮抗剂.本文还披露了所述化合物作为a2A受体拮抗剂在潜在的治疗或预防涉及a2A受体的神经系统疾病和疾病中的用途.本文还披露了包含这些化合物的药物组合物以及这些药物组合物的用途.
海关参考信息
- 2912110000-甲醛
2912120000-乙醛
2914110000-丙酮
2914120000-丁酮 - 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
- 详情请参考：📖 海关编码查询和海关进出口税则
专利信息
专利号:US-2022363662-A1
优先权日:2021-04-20
标题 :Compounds as lxr agonists
发明人：PUJALA BRAHMAM; SATHE BALAJI DASHRATH; DANODIA ABHINANDAN; GUPTA ASHU; SONI SANJEEV; KUMAR VIVEK; ANSARI AMANTULLAH; KHAN FARHA; SARKAR ARINDAM; PAYGHAN PAVAN V
权利人:INTEGRAL BIOSCIENCES PRIVATED LTD
摘要:The present invention generally discloses compounds having LXR (the liver X receptor) agonistic activity, to the use of such compounds in the treatment of various disorders such as proliferative disorders, Alzheimer's disease, inflammatory diseases, and diseases characterized by defects in cholesterol and lipid metabolism. Specifically, the present invention discloses compound of formula (IA) which exhibit LXR agonist activity, specifically to LXRβ. The invention also discloses method of synthesis of said compounds, method of using said compounds, pharmaceutical compositions comprising said compounds and method of using thereof.
